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AMPA-type glutamate receptors (GluRs) play major
roles in excitatory synaptic transmission. Neuronal
AMPA receptors comprise GluR subunits and trans-
membrane AMPA receptor regulatory proteins
(TARPs). Previous studies identified five mammalian
TARPs, g-2 (or stargazin), g-3, g-4, g-7, and g-8, that
enhance AMPA receptor function. Here, we classify
g-5 as a distinct class of TARP that modulates spe-
cific GluR2-containing AMPA receptors and displays
properties entirely dissimilar from canonical TARPs.
g-5 increases peak currents and decreases the
steady-state currents selectively from GluR2-con-
taining AMPA receptors. Furthermore, g-5 increases
rates of GluR2 deactivation and desensitization and
decreases glutamate potency. Remarkably, all ef-
fects of g-5 require editing of GluR2 mRNA. Unlike
other TARPs, g-5 modulates GluR2 without promot-
ing receptor trafficking. We also find that g-7 regula-
tion of GluR2 is dictated by mRNA editing. These
data establish g-5 and g-7 as a separate family of
‘‘type II TARPs’’ that impart distinct physiological
features to specific AMPA receptors.
INTRODUCTION
Glutamate serves as the major excitatory neurotransmitter in
brain. Fast transmission at glutamate synapses is mediated by
AMPA-, NMDA-, and kainate-type ion channels. The AMPA
subtype induces most of the postsynaptic depolarization that
leads to neuronal firing. This moment-to-moment signaling by
AMPA receptors contributes fundamentally to sensory, motor,
and integrative brain functions. Furthermore, activity-dependent
changes in synaptic AMPA receptor levels contribute to the plas-
ticity that underlies aspects of learning and memory (Bredt and
Nicoll, 2003; Malinow and Malenka, 2002; Sheng and Kim,
2002; Song and Huganir, 2002).
AMPA receptors comprise homo- and heterotetramers of
GluR1-4 subunits, which contain both the glutamate-binding
and ion channel structures (Hollmann and Heinemann, 1994;
Seeburg, 1993). These subunits show distinct ion channel con-
ductances and kinetic properties. Alternative splicing, which
yields flip and flop forms for each GluR subunit, further amplifies
this diversity (Sommer et al., 1990). Importantly, editing of the986 Neuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc.GluR2mRNA changes a crucial Gln (Q) to Arg (R) in the ion chan-
nel pore region such that GluR2-containing AMPA receptors
permeate only monovalent cations, whereas GluR2-lacking
receptors also conduct Ca2+ (Hollmann et al., 1991; Sommer
et al., 1991). Some studies suggest that ‘‘subunit-specific rules’’
differentially control AMPA receptor trafficking and synaptic
plasticity (Lee et al., 2004; Malinow and Malenka, 2002; Song
and Huganir, 2002). Supporting these models for subunit-spe-
cific regulation of trafficking, certain binding partners for AMPA
receptors associate specifically with GluR1 or GluR4 subunits,
which have long cytoplasmic tails, whereas other interacting
proteins bind to GluR2 or GluR3 subunits, which have short
cytoplasmic tails.
In addition to the GluR principal subunits, neuronal AMPA re-
ceptors also contain TARP auxiliary subunits (Nicoll et al., 2006;
Vandenberghe et al., 2005b). Mutation of stargazin (or g-2), the
prototypical TARP, yields stargazer mice, which suffer absence
epilepsy and cerebellar ataxia (Letts et al., 1998). This ataxia is
associated with selective loss of AMPA receptor function in cer-
ebellar granule cells (Chen et al., 2000; Hashimoto et al., 1999).
Cellular studies of stargazer granule cells showed that stargazin
escorts AMPA receptors through the secretory pathway to the
synapse (Chen et al., 2000; Vandenberghe et al., 2005a). In ad-
dition to trafficking AMPA receptors, stargazin also modulates
receptor pharmacology and controls channel gating. Specifi-
cally, stargazin increases AMPA receptor glutamate affinity,
enhances single-channel conductance, slows deactivation and
desensitization, and reduces the extent of desensitization (Bed-
oukian et al., 2006; Priel et al., 2005; Tomita et al., 2005; Turetsky
et al., 2005). Furthermore, a family of three other highly homolo-
gous TARPs, g-3, g-4, and g-8, regulate AMPA receptors in dis-
tinct cell types throughout the brain (Tomita et al., 2003). These
four TARPs all show qualitatively similar regulation of all four
GluR isoforms; however, distinct TARP subunits show differ-
ences in their modulation of channel gating. Specifically, g-4
shows the quantitatively greatest effect to slow AMPA receptor
gating (Cho et al., 2007; Korber et al., 2007b; Kott et al., 2007;
Milstein et al., 2007).
TARPs were originally named ‘‘g-subunits’’ based on their
sequence homology with the g-1 tetraspanning calcium channel
subunit (Jay et al., 1990), which occurs only in skeletal and
cardiac muscles and does not regulate AMPA receptors (Tomita
et al., 2003). The extended g-subunit family contains the four
canonical TARPs, as well as g-1, -5, -6, and -7. Our original stud-
ies showed that g-1 and g-5 do not augment trafficking or gating
of GluR1 (Tomita et al., 2003). Whereas g-1 and g-6 occur largely
in striated skeletal muscle, we recently reported that the highly
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g-7—but not g-5—greatly enhances glutamate-evoked currents
from GluR1 (Kato et al., 2007). Further, we found that g-7—but
not g-5—partially restores functional AMPA receptors on star-
gazer cerebellar granule cells.
Here, we examine possible roles for g-5 in regulating AMPA re-
ceptors. Using an optimized immunoprecipitation procedure, we
demonstrate that g-5 associates with several GluR subunits in
solubilized brain extracts. In heterologous cells, we find a unique
subunit specificity forg-5 in regulatingGluRchannel activity. That
is, g-5 enhances glutamate-evoked currents only from certain
GluR2-containing receptors. The critical mRNA-edited Q/R site
in the pore of GluR2 mediates this remarkable specificity. g-5
also uniquely and greatly lowers glutamate affinity and markedly
suppresses steady-state currents, especially from GluR2-con-
taining receptors. Interestingly, g-5 mediates all these regulatory
effects without enhancing cellular trafficking of GluR subunits.
The highly homologousg-7 subunit shares someof these proper-
ties with g-5. These studies define g-5 and g-7 as a subfamily of
type II TARPs as compared to the type I TARPs,g-2,g-3,g-4, and
g-8. This dichotomy of TARP function adds to the diversity of
AMPA receptor physiology and plasticity.
RESULTS
Previous studies showed that g-5 is weakly and specifically
bound to GluR1 in cerebellar extracts (Kato et al., 2007). Here,
we optimized the immunoprecipitation procedure by increasing
the amounts and concentrations of solubilized membrane pro-
teins and antibodies. This improved procedure showed specific
binding of g-5 with GluR1, GluR2/3, and GluR4 in cerebellar ex-
tracts (Figure 1A). We previously showed that g-5 in cerebellum
does not occur in the PSD (Kato et al., 2007), which could reflect
the enrichment of g-5 in cerebellar Bergman glia that lack PSD
domains. To determine whether g-5 in forebrain neurons might
be enriched in the PSD, we fractionated membranes from olfac-
tory bulb. We find that g-5 in these preparations did partially
enrich in the PSD and showed a similar fractionation as g-2,
-3, -4, and -8 (Figure 1B). As our anti-g-5 antibody is not suitable
for immunostaining of endogenous g-5, we overexpressed g-5 in
cultured cortical neurons and coimmunostained with anti-PSD-
95. Strong g-5 signals were observed in somatic regions, and
g-5 was also concentrated in puncta along the neurites. Many
of these g-5 puncta colocalized with PSD-95 (see Figure S1
available online), implying a synaptic distribution.
Subunit-Specific Regulation of GluR by Type II TARPs
We next used whole-cell recordings from transfected HEK293
cells to evaluate regulation of AMPA receptors by g-5. Individual
cells were captured and perfused with a 16-barrel pipette array,
which allowed for rapid sequential titration of pharmacological
reagents. In HEK293 cells transfected with the flip form of
GluR1 alone, glutamate application elicited a peak current of
2000 pA, which rapidly decayed to a steady-state current
of 20 pA (Figure 2A). As previously reported (Tomita et al.,
2003), cotransfection with g-5 did not significantly alter either
the peak or steady-state currents evoked from GluR1. By con-
trast, cotransfection of GluR1 with g-2 or g-7 augmented boththe peak and steady-state currents (Figure 2A). As previously
published (Kato et al., 2007), the glutamate-evoked currents
from cells expressing GluR1 and g-7 showed an unusual kinetic
course comprising an initial peak and desensitization followed
by a slower ‘‘run-up’’ in conductance to reach steady-state (Fig-
ure 2B). For these and all studies, we found that g-6, a striated
muscle protein that shares highest homology with g-1, was
without effect on glutamate-evoked currents.
In contrast to the lack of effect of g-5 on GluR1 responses,
coexpression of g-5 with GluR2 markedly enhanced the peak
current from these receptors (Figures 2A and 3). This enhance-
ment of peak current by g-5 was coupled with a nearly complete
elimination of steady-state current from GluR2 (Figures 2A, 2B,
and 3). The augmentation of GluR2 glutamate-evoked peak
current and reduction of steady-state current reveals an unap-
preciated role for g-5 as a TARP isoform that enhances the ex-
tent of AMPA receptor desensitization. In comparison, g-2 and
g-7 exhibited classical TARP activity by augmenting both the
peak and the steady-state glutamate-evoked currents from
GluR2 (Figures 2A, 2B, and 3). Of note, the effects of g-7 on
GluR2 were similar to its effects on GluR1 such that there was
an enhancement of peak current followed by rapid desensitiza-
tion and a subsequent gradual increase to steady-state current
(Figure 2B).
We further evaluated the effects of g-2, g-5, and g-7 on GluR3
and GluR4. As previously published, g-2 enhanced both the
peak and steady-state currents from cells transfected with
GluR3 or GluR4 (Figure 3). In contrast, g-5 and g-7 had no
effects on the peak current of GluR4 and even reduced that of
GluR3. For steady-state currents, g-5 had minimal effects
whereas g-7 increased steady-state currents from GluR3, but
not GluR4.
Because of the extremely rapid desensitization of AMPA
receptors, the maximal currents measured in our experiments
underestimate the true peak current. To better assess the effects
of TARPs on the maximal peak glutamate-evoked currents, we
added cyclothiazide (CTZ), which blocks desensitization of the
Figure 1. g-5 Associates with Neuronal AMPA Receptors
(A) Cerebellar (Cb) or cerebrocortical (Ct) membraneswere solubilized with Tri-
ton X-100 (0.1%) and immunoprecipitated (IP) with preimmune IgG or anti-g-5
antibody, and bound proteins were immunoblotted with anti-GluRs or anti-g-5
antibodies.
(B) Subcellular fractionation of rat olfactory bulb. g-5 is enriched in P3, P4, LP2,
and synaptosomal fractions and also occurs in the PSD. The distribution re-
sembles that of g-2/3/4/8 and GluR1/2/3, whereas PSD-95 is enriched in
and synaptophysin is absent from PSD.Neuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc. 987
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GluR2-Containing AMPAR Regulated by Type II TARPsFigure 2. g-5 Modulates GluR2 but Not GluR1 Homomeric AMPA Receptors
(A and B) Glutamate-evoked whole-cell currents from HEK293T cells transfected with GluR1 or GluR2 alone or with g-2, g-5, g-6, or g-7. (A) g-5 increased
glutamate-evoked peak currents fromGluR2iR, but not those from GluR1iQ. g-2 and g-7 increased the currents of both GluR2iR and GluR1iQ. g-6 had no effects
on either GluR2iR or GluR1iQ. Open-tip recording determined the speed of perfusate switching. Extended time scale (B) shows that g-5 reduced the steady-state
currents from GluR2iR evoked by glutamate but had no effect on steady-state currents from GluR1iQ. g-2 and g-7 increased currents from both GluR2iR and
GluR1iQ.
(C) Currents evoked by glutamate (1 mM) in the presence of CTZ (40 mM). g-5 increased the currents from GluR2iR but not GluR1iQ.flip isoform of GluR subunits. Consistent with previous findings
(Kott et al., 2007), g-2 enhanced the responses of GluR1-4 to
glutamate in the presence of CTZ (Figures 2 and 3). In marked
contrast, both g-5 and g-7 selectively enhanced the maximal
glutamate-evoked current of GluR2 in the presence of CTZ
with minimal effects on GluR1, GluR3, and GluR4. Collectively,
the preceding data in the absence and presence of CTZ demon-
strate that, in contrast to the augmentation of all GluRs by the
type I TARPs, including stargazin (Kott et al., 2007), g-5 and
g-7 selectively enhance responses of GluR2 and GluR1-2,
respectively. This characteristic and others described below
distinguish g-2, g-3, g-4, and g-8 from g-5 and g-7; therefore,
we will hereafter refer to these families as type I TARPs and
type II TARPs, respectively.
As GluR1 coimmunoprecipitated with g-5 from cerebellum
(Figure 1A), we explored functional modulation of GluR1 by
g-5. Recent studies showed that type I TARPs modulate the rec-
tification of AMPA receptor-mediated currents (Kott et al., 2008;
Soto et al., 2007). Similar to type I TARPs, g-5 (and g-7) also
modulated the rectification of GluR1 currents (Figure S2), imply-
ing that g-5 physically associates with GluR1. Our functional
data suggest that type II TARPs also bind to GluR3 homomers,
as g-5 and g-7 reduced the peak currents of GluR3, and g-7 in-
creased steady-state currents of GluR3 (Figure 3). These obser-
vations indicate that type II TARPs associate broadly with GluRs,
but that regulation is strictly subunit specific.
The Q/R Site in GluR2 Determines Subunit-Selective
Gating of Type II TARPs
The differential effects of g-5 on gating of GluR2 versus other
subunits suggested a possible role for the ‘‘Q/R site’’ in the
pore region of the channel, which undergoes mRNA editing
only in GluR2 to produce an Arg residue that regulates channel
rectification and ion permeability (Sommer et al., 1991). To deter-988 Neuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc.mine the contribution of this site to type II TARP modulation of
GluR2, we mutated this residue in GluR2 to Gln (Q). Strikingly,
we found that the enhancing effects of g-5 on both the gluta-
mate-evoked peak current and CTZ-enhanced maximal current
were eliminated in GluR2Q (Figure 3). In addition, g-7 enhanced
only the steady-state currents of GluR2Q, and g-7 had no effect
on peak currents in the absence or presence of CTZ. In contrast,
g-2 modulation of glutamate-evoked peak, steady-state, and
CTZ-enhanced currents was unaffected by the Gln mutation
(Figure 3). To evaluate further the dependence of g-5 effects
on Q/R editing, we constructed an unnatural R-form of the flip
splice variant of GluR1. Similar to its effects on GluR2iR, g-5
enhanced glutamate-evoked peak and steady-state currents
through GluR1iR, as well as the currents evoked by glutamate
in the presence of CTZ. Furthermore, g-5 reduced by 7-fold
the potency of glutamate for GluR1iR (Figure S3). Quantitatively,
all TARPs tested here showed larger increases of GluR2R-medi-
ated currents as compared to GluR2Q receptors (Figure 3). This
preferential effect of TARPs on R-forms is also observed in
GluR1iR (Figure S3). As virtually all GluR2 subunits, but no other
AMPA receptor subunits are edited at the Q/R site (Sommer
et al., 1991), these data suggest that only neuronal receptors
containing the GluR2 subunit would be enhanced by g-5.
g-5 Accelerates GluR2 Channel Deactivation
and Desensitization
The preceding results demonstrate that g-5 uniquely modulates
GluR2 by enhancing peak currents and suppressing steady-
state responses. A hallmark of type I TARPs is their ability to
slow AMPA receptor gating by modulating the deactivation
and/or desensitization processes of these ion channels. To
determine the extent to which g-5 modulates these biophysical
processes, we compared the effects of coexpression of g-2 or
g-5 on deactivation and desensitization of GluR2. To evaluate
Neuron
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perfusion of 1 ms pulses of glutamate to outside-out patches
(Figure 4A). Because GluR2 subunits show very small channel
conductances (Swanson et al., 1997), we could not detect gluta-
mate-evoked currents in patches from cells transfected with
GluR2R alone (data not shown). However, cotransfection with
GluR2Rwith either g-5 or g-2 yielded readily detectable currents.
Results showed that the deactivation rates of these currents
were significantly faster in cells transfected with g-5 as
compared to g-2 (Figures 4A and 4C).
To evaluate desensitization we used ultrafast application of
glutamate to isolated cells, which allowed detection of currents
from GluR2iR transfectants. We found that g-2 slowed the
desensitization of GluR2iR (Figures 4B and 4D), but to a lesser
extent than seen previously with GluR1i (Tomita et al., 2005).
By contrast, g-5 accelerated the desensitization rate of GluR2iR
currents (Figures 4B and 4D). Furthermore, g-2 enhanced
steady-state currents from GluR2i(R), whereas g-5 nearly
abolished these currents (Figure 4E).
In an attempt to confirm that endogenously expressed g-5 can
influence the function of native AMPA receptors, we took advan-
tage of the selective expression of g-5 in the CA2, but not the
CA1 or CA3 pyramidal cells of the hippocampus (Figure 4F;
Fukaya et al., 2005; Lein et al., 2007). We assessed AMPA recep-
tor-mediated desensitization in acutely isolated CA2 and CA3
Figure 3. Subunit-Specific Modulation of
GluR Homomers by Type II TARPs
Peak and steady-state currents were recorded
from HEK293T cells transfected with GluR1iQ,
GluR2iR, GluR2iQ, GluR3iQ, or GluR4iQ and g-2,
g-5, or g-7 in response to application of glutamate
(1mM) alone (left andmiddle panels) or in the pres-
ence of CTZ (40 mM) (right panel). g-5 regulates
GluR2iR robustly but has minimal effects on other
AMPA receptor subunits. g-5 does not enhance
the maximal currents evoked by glutamate in the
presence of CTZ from the ‘‘unedited’’ GluR2iQ,
indicating that Q/R editing of GluR2 is critical for
regulation by g-5. g-7 robustly amplifies currents
from GluR1iQ, GluR2iQ, and GluR2iR, but not
GluR3iQ or GluR4iQ. In contrast, g-2 regulates all
AMPAR subunits. Error bars, SEM. Statistical sig-
nificance with respect to no TARPs (Student’s t
test): *p < 0.05, **p < 0.01.
hippocampal pyramidal neuron using
ultrafast glutamate application. Results
showed that the rate of desensitization
of AMPA-receptor-mediated currents
from CA2 neurons was significantly faster
than that from CA3 neurons (Figures 4G
and 4H). In addition the extent of desensi-
tization was greater in CA2 neurons than
CA3 neurons, as revealed by a lower
steady-state to peak current ratio (Fig-
ures 4G and 4I). Taken together, these
data support the hypothesis that g-5
can uniquely modulate the biophysical properties of native
neuronal AMPA receptors.
g-5 Decreases Agonist Affinity for GluR2 Subunits
Previous studies showed that type I TARPs increase the affinity
of GluR1 receptors for glutamate, whereas g-7 does not alter ag-
onist affinity (Kato et al., 2007). Here, similar to the effects of g-7,
the present results showed that g-5 had no effect on glutamate
affinity for GluR1 (Figure 5). However, for GluR2, g-5 lowered
the glutamate affinity by 10-fold, and this effect was restricted
to the edited form of GluR2(R) (Figure 5). Evaluation of GluR1/2
heteromers revealed that g-5 had an intermediate effect, pro-
ducing 3-fold rightward shift in glutamate affinity. To confirm
that our GluR1 and GluR2 cotransfectants formed heteromeric
receptors, we assessed channel rectification. As shown in
Figure S4, GluR1/2 and GluR2/3 cotransfectants showed similar
rectification indices to GluR2 homomers, which is consistent
with the dominant influence of GluR2 on heteromeric receptor
rectification (Hollmann et al., 1991; Sommer et al., 1991).
g-5 Does Not Enhance GluR Subunit Surface Trafficking
Previous work has shown that g-2 enhances surface expression
of AMPA receptors in both neurons and nonneuronal cells (To-
mita et al., 2005). In COS cells, trafficking by g-2 can be quanti-
fied by staining transfected cells for an extracellular epitope onNeuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc. 989
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(Vandenberghe et al., 2005a). Using this assay, we found in the
present studies that g-2 enhanced the cellular trafficking of
GluR1 and GluR2. By contrast, g-5 did not augment the cellular
trafficking of either GluR1 orGluR2 (Figures 6A and 6B). As a sec-
ond method to quantify surface AMPA receptors, we employed
a membrane-impermeable divalent crosslinker, bis[sulfosuccini-
midyl]suberate (BS3), which selectively crosslinks surface pro-
teins (Hall and Soderling, 1997). g-2, but not g-5, selectively
increased crosslinked AMPA receptors (Figure 6C). Collectively,
Figure 4. g-5 Accelerates Deactivation and Both Accelerates and
Enhances the Extent of Desensitization of GluR2iR-Containing
AMPA Receptors
(A–E) HEK293T cells were transfected with GluR2iR alone or GluR2iR with g-2
or g-5. The kinetics of deactivation and desensitization and the ratio of steady-
state to peak currents were quantified. (A and B) Typical traces of deactivation
([A] left, unscaled; right, scaled) and desensitization (B). Bars show glutamate
application. Black, GluR2iR alone; blue, GluR2iR + g-2; red, GluR2iR + g-5. (C)
Outside-out patches from the transfected cells held at 80 mV were perfused
with glutamate for 1 ms. GluR2iR + g-5 shows faster deactivation kinetics than
GluR2iR + g-2. The traces were fit with a single exponential function. Gluta-
mate-evoked currents from patches of GluR2iR without TARPs were not de-
tectable (data not shown). (D) g-5 accelerates and g-2 decelerates the rate
of GluR2iR desensitization. Desensitization traces were fit using a single expo-
nential function. (E) g-5 reduces and g-2 increases the ratio of steady-state to
peak current amplitude. Error bars, SEM. Statistical significance with respect
to g-2 (C) and no TARPs (D and E), respectively (Student’s t test [C], Fisher’s
LSD [D and E]).
(F) In situ hybridization from the Allen Brain Atlas (Lein et al., 2007) shows broad
expression of g-2 in hippocampal pyramidal neurons and selective localization
of g-5 in CA2 (arrowheads) pyramidal neurons.
(G) Typical traces of AMPA receptor-mediated currents evoked by glutamate
in acutely isolated CA2 (red) and CA3 (blue) hippocampal pyramidal neurons.
Glutamate was perfused using a piezoelectric actuator.
(H and I) Desensitization occurred faster (H) and to a greater extent (I) in CA2 as
compared to CA3 pyramidal neurons.990 Neuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc.these data indicate that the influence of g-5 on AMPA receptors
is restricted to effects on ligand binding and channel gating.
Type II TARPs Differentially Regulate
Heteromeric AMPA Receptors
Many neuronal AMPA receptors comprise heterotetramers. Pre-
vious studies have indicated that GluR1/2 heteromeric receptors
represent the primary AMPA receptor type in hippocampal
neurons, whereas GluR2/3 heteromeric receptors represent
a prominent subunit combination in principal neurons of cerebral
cortex (Geiger et al., 1995). In the present studies, coexpression
of either g-2 or g-7 with GluR1/2 robustly augmented the peak
and steady-state currents (with or without CTZ) from these
receptors compared to either GluR1 or GluR2 alone, whereas
g-5 was without effect on GluR1/2 heteroreceptors (Figure 7).
In contrast, all three TARPs enhanced glutamate-evoked
currents from GluR2/3-expressing cells (Figure 7).
Several previous studies of TARPs have focused on rescue ex-
periments in stargazer cerebellar granule cells (Chen et al., 2000;
Kato et al., 2007; Tomita et al., 2003), which predominately ex-
press flop isoforms of GluR2 and GluR4 (Monyer et al., 1991).
These studies showed that type I TARPs fully restored functional
AMPA receptors, whereas g-7 only partially rescued functional
AMPA receptors and g-5 had no effect (Kato et al., 2007). We
modeled these cerebellar granule cell experiments by cotrans-
fecting the flop isoforms of GluR2 and GluR4 with g-2, g-5, or
g-7 and then assessed currents evoked by glutamate in the
presence of CTZ. Mimicking the results reported previously
from stargazer granule cells (Kato et al., 2007), g-2 robustly en-
hanced currents, g-7 had a lesser effect, and g-5 was inactive
(Figure S5).
g-5 Modulates Neuronal AMPA Receptors
Our experiments described above using acutely isolated CA2
and CA3 neurons indicated that endogenous g-5 can influence
channel gating of neuronal AMPA receptors. To assess further
the effects of g-5 in neuronal receptors, we transfected this
TARP into cerebrocortical neurons, which normally express sig-
nificant GluR2/3 heteromers. Cultured neurons from rat embryos
were transfected on DIV 3 and recorded DIV 8. To evaluate
deactivation and desensitization kinetics, we measured AMPA
receptor-mediated currents from pulled outside-out patches
held at 80 mV and perfused with a glutamate solution contain-
ing GABAA and NMDA receptor blockers. In outside-out patches
from these neurons, we found that—similar to its effects on
GluR2—g-5 transfection in cerebrocortical neurons increased
the rate and dramatically enhanced the extent of AMPA receptor
desensitization (Figures 8A–8C). Note that outside patches have
a much smaller surface area and can be efficiently perfused with
an ultrafast system; therefore, steady-state/peak current ratios
in Figures 8A and 8C were significantly smaller than those in
Figure 4I, which used whole-cell recordings. In these experi-
ments, currents recorded from cells cotransfected with g-5
showed a trend toward faster rates of deactivation, but this effect
was not significant (Figures 8D and 8E). In addition, a concentra-
tion-response analysis showed that g-5 reduced glutamate
potency by 2-fold (Figure 8F).
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GluR2-Containing AMPAR Regulated by Type II TARPsFigure 5. g-5 Lowers the Affinity of Glutamate on GluR2R-Containing AMPA Receptors
(A–D) Concentration-response profiles for glutamate (in the presence of 40 mM CTZ) measured from HEK293T cells expressing GluRs either alone or with g-5.
Coexpression with g-5 decreased the potency of glutamate for GluR2iR homomer and GluR1iQ/GluR2iR heteromer, but not from GluR1iQ homomer. Also, g-5
did not change the potency of GluR2iQ, indicating that the g-5 effect on glutamate potency requires mRNA editing.DISCUSSION
g-5 and g-7 Represent a Distinct Family of TARPs
These studies demonstrate multiple effects of g-5 on AMPA
receptors that differ dramatically from the actions of the originally
identified TARPs, and thereby identify g-5 as a distinct TARP iso-
form. First, g-5 shows specificity to enhance glutamate-evoked
currents from receptors containing the R-edited form of GluR2.
Second, g-5 markedly lowers the affinity of certain AMPA recep-
tors for glutamate. Third, g-5 enhances maximal currents of
GluR2 subunits while simultaneously reducing steady-state
currents. Finally, g-5 mediates all these channel effects without
promoting the surface expression of GluR2. As g-7 shows ex-
tremely high sequence homology with g-5 and shares some of
these unique regulatory properties, we now define these two
proteins as type II TARPs.
While surprising, thesedata are entirely consistentwith our pre-
viously published data on g-5 and g-7. Several studies have
shown that g-5 does not promote surface trafficking or gluta-
mate-evoked currents from GluR1 homomers (Tomita et al.,
2003). In addition, previous studies have demonstrated that g-5
does not augment glutamate-evoked currents in stargazer gran-
ule cells, which primarily express GluR2 and GluR4 flop isoforms
(Tomita et al., 2003). Furthermore, g-7 only modestly enhancesmaximal glutamate-evoked currents in transfected stargazer
granule cells (Kato et al., 2007). As these studies with stargazer
granule cells transfected with g-7 used glutamate in the presence
of CTZ, they are consistent with the present results showing that
g-7 only moderately augments currents from GluR2/GluR4 flop
heteromers treated with Glu and CTZ. Finally, previous work has
shown that a chimeric construct of stargazin containing the extra-
cellular domain of g-5 accelerates the decay kinetics of EPSCs in
transfected hippocampal neurons (Tomita et al., 2005) consistent
with the ability of g-5 to accelerate receptor deactivation.
g-5 Controls Only Channel Gating,
Not Receptor Trafficking
The original studies implied that stargazin functions solely by pro-
motingAMPA receptor trafficking (Chenet al., 2000). Subsequent
experiments showed that stargazin and all type I TARPs control
both AMPA receptor trafficking and gating (Bedoukian et al.,
2006; Priel et al., 2005; Tomita et al., 2005; Turetsky et al.,
2005). Inmarked contrast to the effects of type I TARPS, the pres-
ent results indicate that g-5 functions only to regulate AMPA
receptor gating. As a consequence, the mechanisms underlying
the enhancement ofmaximal currents fromGluR2byg-5 likely in-
volve the augmentation of single-channel conductance and/or
burst times as have been reported for stargazin (Tomita et al.,Figure 6. g-5 Effects on GluR2-Containing
AMPA Receptors Do Not Involve Cell Sur-
face Protein Trafficking
(A and B) CHO cells coexpressing HA-tagged
GluR1iQ or untagged GluR2iR/2iQ with g-2 or g-
5 were labeled with an antibody to the HA-tag or
to the ectodomain of GluR2 without permeabiliza-
tion. After fixation and permeabilization, the cells
were incubated with an antibody to the cytoplas-
mic domain of GluR1 or GluR2 as indicated. (A)
Typical images of surface and total staining of
GluR2 either alone or coexpressed with g-2/5.
(B) The ratios of surface to total GluR1/2-positive
cell were quantified by an observer blinded to
the transfection condition. Error bars, SEM. Statis-
tical significance with respect to no TARPs (Stu-
dent’s t test): **p < 0.01.
(C) CHO cells expressing GluRs and g-subunits
were treated with a membrane-impermeable crosslinker, BS3. After washing the cells with buffer containing primary amine, proteins were separated by SDS-
PAGE and blotted with anti-GluR1 or anti-GluR2/3 antibodies. Intracellular GluRs were detected as monomers at 100 kD, whereas surface GluRs migrated
at higher molecular weight. g-2 but not g-5 increased crosslinked GluRs, indicating that the surface trafficking of GluRs was promoted by g-2 but not by g-5.Neuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc. 991
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GluR2-Containing AMPAR Regulated by Type II TARPsFigure 7. g-5 Preferentially Regulates AMPA Receptor Heteromers Composed of GluR2/3 Subunits
Peak and steady-state currents were recorded from HEK293T cells transfected with GluR1iQ/GluR2iR or GluR2iR/GluR3iQ and g-2, g-5, or g-7 in response to
application of glutamate (1 mM) alone (left and middle panels) or in the presence of CTZ (40 mM) (right panel). These GluR combinations were chosen to represent
cortical and hippocampal neurons, which mainly express GluR1iQ/GluR2iR and GluR2iR/GluR3iQ, respectively. g-5 enhanced peak currents to glutamate alone
andmaximal currents in the presence ofCTZ fromGluR2iR/GluR3iQ but not fromGluR1iQ/GluR2iR. In contrast, g-2 and g-7 regulated both heteromers in a similar
manner. Error bars, SEM. Statistical significance with respect to no heteromers in the absence of TARPs (Student’s t test): *p < 0.05, **p < 0.01.2005). The inability ofg-5 topromote surfaceexpression ofAMPA
receptors resembles aC. elegans stargazin-like molecule, which
reconstitutes functional invertebrate glutamate-gated channels
without a role in receptor trafficking (Walker et al., 2006). It is in-
teresting to speculate that perhaps type II TARPs initially derived
from their C. elegans orthologs, and later type I TARPs evolved
capacity for AMPA receptor trafficking.
Type II TARPs Have Unique Effects on Glutamate
Affinity and Channel Gating
Previous studies have shown that all type I TARPs increase af-
finity of glutamate for AMPA receptors and as a consequence
slow the deactivation process. In addition, type I TARPs all de-
celerate the rate of AMPA receptor desensitization and attenu-
ate the extent of receptor desensitization (Bedoukian et al.,992 Neuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc.2006; Priel et al., 2005; Tomita et al., 2005; Turetsky et al.,
2005). In striking contrast, the present studies show that g-5
reduces the affinity of glutamate for GluR2-containing AMPA
receptors and as a result accelerates receptor deactivation. In
addition, g-5 increases the both the rate and extent of AMPA
receptor desensitization such that the steady-state currents of
GluR2-containing receptors are nearly abolished. Previous
studies have shown that g-7 also has distinct effects from
type I TARPs in that it does not alter the affinity of AMPA recep-
tors for glutamate and has only minimal effects on the rate of
receptor deactivation (Kato et al., 2007). Intriguingly, g-7 imparts
an unusual effect on the desensitization process of GluR1 and
GluR2 receptors marked by an initial decay in current from the
peak response followed by a slow increase in current to steady
state.Figure 8. Transfection of g-5 into Neuronal
AMPA Receptors Modifies Their Gating
Properties
Dissociated cultures from rat cerebral cortices
were transfected with either g-5 and GFP or GFP
alone.
(A) Typical traces recorded from the outside-out
patches evoked by 100–400 ms application of
100 mM glutamate. Inset shows the currents
recorded at the times indicated by the arrows 1
and 2. Black and red traces represent recordings
from cells expressing GFP alone and g-5 plus
GFP, respectively.
(B) g-5 (n = 10) significantly accelerated desensiti-
zation of neuronal AMPA receptors (n = 9).
(C) Steady-state currents were recorded before
and 90–390 ms after the application of glutamate.
g-5 (n = 10) reduced steady-state currents of
AMPA receptors (n = 9).
(D) Typical traces recorded from outside-out patches evoked by 1 ms application of 100 mM glutamate. Black, GFP alone; red, g-5 plus GFP.
(E) Coexpression of cortical neurons with g-5 produced a tendency toward an increase in the rate of deactivation.
(F) Concentration-response profiles for glutamate (in the presence of 40 mM CTZ) measured from cultured neurons with and without g-5. Results showed that
transfection of g-5 into cortical neurons reduced the potency of glutamate at the receptor. Error bars, SEM. Statistical significance with respect to recordings
in the absence of g-5 coexpression (Student’s t test): *p < 0.05.
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by Type II TARPs
Whereas type I TARPs can potentiate all AMPA receptor combi-
nations (Kott et al., 2007), type II TARPs display exquisite sub-
unit-specific regulation. g-7 enhances peak currents only from
channels containing GluR1 or GluR2. g-5 displays even stricter
specificity in that it augments currents only from GluR2-contain-
ing AMPA receptors for which a single amino acid in the pore re-
gion has been edited from aglutamine to an arginine residue. The
arginine in edited forms of GluR2 confers low calcium permeabil-
ity (Sommer et al., 1991), low single-channel conductance
(Swanson et al., 1997), and an approximately linear current-
voltage relation even in heteromeric receptors (Verdoorn et al.,
1991). This mRNA editing of GluR2 is critical for normal develop-
ment and survival, as mice engineered with an editing deficiency
in GluR2 display severe neurological impairment and premature
death (Brusa et al., 1995). The importance of Q/R site editing of
GluR2 notwithstanding, the present results indicate that the peak
monovalent cation current through either homomeric GluR2R
receptors or GluR2R/GluR3 receptors can be enhanced by
coexpression with multiple TARPs. However, unlike the effects
of other TARPs, g-5 would be expected to rapidly terminate
current through these receptor subtypes through acceleration
of the deactivation and desensitization. Given the heteroge-
neous distribution of TARPs in the CNS, these data suggest
that the permeability of GluR2-containing AMPA receptors can
be fine-tuned in specific brain regions.
The mechanistic basis for this subunit specific specificity
remains unclear. Previous work showed that TARPs interact
with both the extracellular glutamate binding module and the
transmembrane domains of AMPA receptors (Tomita et al.,
2004, 2007). The selective regulation of edited GluR2 by g-5 sug-
gests that TARPs may also interact with the ion channel pore. In-
terestingly, recent studies have shown that stargazin regulation
of GluR1 depends critically upon this same Q/R residue (Korber
et al., 2007a). Furthermore, stargazin and other type I TARPs
attenuate intracellular polyamine block of calcium permeable
AMPA receptors, which is dictated by the Q residue in non-
GluR2 subunits (Soto et al., 2007). Whether TARPs directly
bind to or allosterically regulate this constricted region of the
AMPA receptor pore will require structural studies.
Roles for Type II TARPs in AMPA Receptor
Physiology and Plasticity
The present data have important implications for AMPA receptor
physiology in synaptic transmission and plasticity. Though our
antibody was unsuitable for immunohistochemistry, in situ
hybridization as part of the Allen Brain Atlas (Lein et al., 2007)
shows thatg-5mRNA is enriched inBergmanglia, aswell as a va-
riety of neuronal populations including locus coeruleus, olfactory
bulb, lateral septal nucleus, interpeduncularnucleus,and theCA2
and rostral/medial CA1 regions of hippocampus (Figure S6). The
regulatory features of g-5 may underlie unique properties of
AMPA receptors in these cell types. Previous studies indicate
that AMPA receptors in Bergmann glia show very rapid channel
gating, consistent with the regulatory properties conferred by
g-5. Likewise, the present studies show that hippocampal CA2
neurons that express g-5 display more rapid and more completeAMPA receptor desensitization than CA3 neurons which do not
contain this TARP. The extent to which g-5 expression confers
a unique phenotype in AMPA receptor gating in other cell types
that express multiple TARPS will require future studies.
The subunit-specific regulation of AMPA receptors by type II
TARPs has important physiological implications. Previous work
has suggested that subunit-specific rules govern the trafficking
and plasticity of neuronal AMPA receptors. Specifically, recep-
tors containing long C-terminal tailed GluR1 are suggested to
traffic in a regulated fashion to mediate long term potentiation,
whereas receptors containing only short-tailed GluR2/3 are
thought to traffic constitutively and mediate long-term depres-
sion (Lee et al., 2004; Malinow andMalenka, 2002; Song and Hu-
ganir, 2002). PDZ domain interactions with the distinct C termini
of short- and long-tailed GluR subunits have been suggested to
underlie these processes; however, certain discrepancies have
arisen (Kim et al., 2005; Meng et al., 2003). The subunit-specific
regulation of GluR subunits by type II TARPsmay also contribute
to synaptic plasticity.
As AMPA receptors require a TARP to traffic to the neuronal
cell surface, type II TARPsmay cooperate with their type I homo-
logs to regulate AMPA receptors expression and function. Sev-
eral possible mechanisms could underlie such collaboration.
The number of TARPs associated with a tetrameric AMPA recep-
tor remains uncertain; however, recent work suggests that this
stoichiometry can vary (Milstein et al., 2007). We previously de-
tected some g-2 in our g-7 immunoprecipitates from cerebellum,
suggesting that these proteins may occur together in neuronal
AMPA receptors (Kato et al., 2007). Our other studies show
that glutamate can cause dissociation of type I TARPs from neu-
ronal AMPA receptors, and this could conceivably lead to an
exchange in TARP isoform regulation once the receptors have
been delivered to the cell membrane (Tomita et al., 2004). Defin-
ing quantitatively TARP stoichiometries and the dynamics of
their interactions with AMPA receptors remain crucial issues. Fu-
ture studies of mice lacking type II TARPs should help elucidate
the role for these proteins in synaptic transmission and plasticity.
EXPERIMENTAL PROCEDURES
Antibodies
The following commercially acquired antibodies were used: rabbit polyclonals
to C-terminal GluR1 (AB1504; Millipore), C-terminal GluR2/3 (AB1506; Milli-
pore), and C-terminal GluR4 (AB1508; Millipore); and mouse monoclonals to
N-terminal GluR2 (MAB397; Millipore) and HA.11 (16B12; Covance). Poly-
clonal antiserum to g-5 was described (Kato et al., 2007).
Subcellular Fractionation
Subcellular fractions were prepared by differential centrifugation as described
(Kato et al., 2007). Briefly, ten rat olfactory bulbs were homogenized in 10ml of
buffer I (0.32 M sucrose, 3 mMHEPES-Na [pH 7.4], 0.1 mg/ml PMSF). The ho-
mogenate was centrifuged at 10003 g to produce a pellet (P1) and a superna-
tant (S1). P1 pellet was resuspended in buffer I and centrifuged at 10003 g to
obtain crude nuclear fraction (P10) and a supernatant (S10). The combined su-
pernatant (S1+S10) was centrifugedat 12,0003g for 15min to produceapellet
(P2) and supernatant (S2). The S2 fraction was centrifuged at 33,000 3 g for
20 min to give a pellet (P3) and a supernatant (S3). The S3 fraction was centri-
fuged at 260,0003 g for 2 hr to produce a pellet (P4) and a supernatant (S4, cy-
tosolic fraction). TheP2pellet was resuspended in theoriginal volumeof buffer I
and centrifuged for 15 min at 13,0003 g to yield the crude synaptosomal frac-
tion (P20). The P20 fraction was resuspended in homogenization buffer andNeuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc. 993
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7.4) and incubated for 1 hr. The lysate was centrifuged for 20min at 33,0003 g
to produce the lysate heavy membrane pellet (LP1) and lysate supernatant
(LS1). The LS1 fraction was then centrifuged for 20 min at 260,000 3 g for 2
hr to give a crude synaptosomal vesicle pellet (LP2) and a cytosolic synapto-
somal supernatant (LS2). In a separate procedure, synaptosomes and PSD
fractions were prepared from ten rat cerebella. The synaptosome fraction
was purified by discontinuous sucrose density gradient centrifugation was ex-
tracted once or twicewith ice-cold 0.5%Triton X-100 in 6mMTris-HCl (pH 7.5)
and then centrifuged to obtain the PSD I and PSD II pellets.
Immunoprecipitation
Immunoprecipitationwasperformedasdescribed (Kato et al., 2007). Briefly, rat
cerebella were homogenized with 3-fold tissue volume of buffer I (0.32 M su-
crose, 3 mM HEPES-Na [pH 7.4], 0.1 mg/ml PMSF) and spun at 20,000 3 g
for 10m at 4C. The resulting pellets were homogenized with 4-fold the original
volume of buffer I and then solubilized with 0.1% Triton X-100 for 1 hr. The
solubilized extracts after centrifugation at 100,000 3 g were precleared by
the addition of protein A-Sepharose (GE Healthcare). This supernatant was
incubatedwith appropriate antibodies (20 mg) for 1 hr and thenwith 25 ml of pro-
tein A-Sepharose for 1 hr. The resultant resin was washed eight times with
buffer I containing 20 mM NaCl. Adherent proteins were eluted with Laemmli
sample buffer with 3% SDS at 55C for 30 min and then 95C for 10 min and
separated by SDS-PAGE. The separated proteins were transferred onto
PVDF membrane and blotted with polyclonal antibodies to GluR1 (1:400),
GluR2/3 (AB1506, 1:400), GluR4 (1:400), and g-5 (1:100).
Cell Culture
Primary cultures of rat cortical neurons were prepared essentially as described
(Kato et al., 2001). Briefly, embryonic Wistar rats (gestational day 19) were re-
moved from euthanized mothers, and the brains were dissected. The cortices
were incubated at 37C for 10min in a papain solution: 5mML-cysteine, 1mM
EDTA, 10 mM HEPES-NaOH (pH 7.4), 100 mg/ml bovine serum albumin,
10 unit/ml papain (Worthington) and 0.02% DNase (Sigma). The reaction
was stopped by addition of an equal volume of fetal bovine serum. The cells
were gently triturated and washed with the plating medium, Neurobasal (Invi-
trogen) supplemented with B-27, 100 mg/ml penicillin, 85 mg/ml streptomycin,
0.5mMglutamine, and 10 mM2-mercaptoethanol. The cells were plated on the
12 mm coverslips coated with poly-D-lysine in 24-well stacks at 100,000 cells/
well density. Fresh plating medium without 2-mercaptoethanol was added
2–3 days after plating (2 ml medium total/well).
A g-5 CMV expression vector (0.1 mg/well) was mixed with a GFP-express-
ing plasmid (0.1 mg/well), andDNA-Lipofectamine 2000 (Invitrogen) complexes
were prepared in Neurobasal medium. Primary neurons (4–5 days in vitro [DIV])
were incubated with these Lipofectamine complexes for 2–5 hr, and the orig-
inal culture medium was retained. After transfection, the cells were washed
twice, and then the conditioned medium was replaced. Electrophysiological
recordings from primary neurons were carried out at 7–9 DIV, which is
3–4 days after transfection.
Exogenous expression of g-5 in primary neurons using a Semliki forest viral
vector was performed as described (Kato et al., 2005). Briefly, g-5 cDNA was
subcloned into pSCA1, and viral particles were produced by transfecting
pSCA1-g-5 and pHelper into HEK293T cells. Supernatants were harvested
48 hr after infection. Prior to infection, the viral particleswere activatedwith chy-
motrypsin.Viral solutionwasadded to thecultures (3weeks invitro), andthecells
were stained 24–48 hr after infection. The cells were fixed and permeabilized
with 100% methanol on ice. After blocking with 7.5% BSA, the rabbit anti-g-5
(1 mg/ml) and the mouse anti-PSD-95 (1:100) antibodies were overlaid onto the
cells. The primary antibodies were visualized with Alexa 488 conjugated anti-
rabbit IgG and Alexa564 conjugated anti-mouse IgG (Invitrogen).
Electrophysiology
Glutamate-evoked currents were recorded from primary cultures of rat cortical
neurons or HEK293T cells transiently transfected with specific GluR subunits
and TARPs using previously described procedures (Kato et al., 2007). Record-
ing electrodes were pulled from borosilicate capillary tubing (Corning 7052;
World Precision Instruments, Sarasota, FL) using a multistage puller (model994 Neuron 59, 986–996, September 25, 2008 ª2008 Elsevier Inc.P-97; Sutter Instruments, Novato CA). The electrodes were fire polished using
a microforge (model MF-830; Narishige, Tokyo, Japan) before use. For exper-
iments using the whole-cell variant of the patch-clamp technique, the internal
electrode solution contained the following: 130 mM CsCl, 2.5 mM MgCl2,
0.5 mM CaCl2, 1 mM EGTA, 10 mM HEPES, 4 mM MgATP, 12 mM phospho-
creatine (pH 7.20 ± 0.03), 280 mOsm adjusted with phosphocreatine. For
experiments measuring the current-voltage relationship of AMPA receptors,
100 mMspermine was added to this internal solution. The extracellular solution
contained: 135 mM NaCl, 5.4 mM KCl, 1.0 mM MgCl2, 1.8 mM CaCl2, 5 mM
HEPES (pH 7.2), 300 mOsm.
Before recording, transfected HEK cells were placed into a 50 mm transpar-
ent plastic Petri dish that was mounted onto the stage of an inverted micro-
scope. After the recording electrode was placed in the extracellular solution
bath, offset potentials were corrected, and electrode resistances ranged
between 2 and 7 MU. Voltage-clamp recordings were made using an Axo-
patch 200B amplifier (Medical Devices Inc, CITY, CA), and currents were dig-
itized andmonitored with pClamp software version 10.2 (Medical Devices Inc.,
CITY, CA) running on a personal computer. The membrane potential of cells
was held at 80 mV unless stated otherwise. A small amount of constant
positive pressure (2–3 cmH2O) was applied to the electrodes as they were ad-
vanced through the bath. After achieving the whole-cell configuration, series
resistance was compensated (70%–85%) and monitored periodically.
Recordings were made from single green fluorescent protein (GFP)-positive
cells at room temperature.
Hippocampal CA2 and CA3 neurons from young male Sprague-Dawley rats
(12–16 days old) were acutely isolated using procedures described previously
(Baumbarger et al., 2001). Brains were removed rapidly and immersed in a cold
(2C) NaHCO3-buffered saline solution containing 120 mM NaCl, 2.5 mM
KCl, 1 mM MgCl2, 1.25 mM Na2PO4, 2 mM CaCl2, 26 mM NaHCO3, and
10mM glucose (pH 7.4), osmolarity 300 ± 5mOsM/l. The brains were blocked,
and 400 mm thick coronal sections were cut using a Vibroslice (Campden In-
struments, London, England). Slices were then incubated at room temperature
in a holding chamber containing the continuously oxygenated (95% O2, 5%
CO2) NaHCO3-buffered saline solution and allowed to recover for at least
30 min. Slices were transferred to a Petri dish containing a low-Ca2 HEPES-
buffered saline solution containing 140 mM NaHOCH2CH2SO3 (Na isethio-
nate), 2 mM KCl, 4 mMMgCl2, 0.1 mMCaCl2, and 15 mMHEPES (pH 7.4), os-
molarity 300 ± 5mOsM/l adjusted with glucose, and placed under a dissecting
microscope. The CA2 or CA3 regions were dissected out from the surrounding
tissue and placed into a holding chamber containing protease type XIV (1 mg/
ml; Sigma-Aldrich, St. Louis, MO) dissolved in oxygenated HEPES-buffered
Hank’s balanced salt solution (HBSS 6136; Sigma-Aldrich) maintained at
37C, pH 7.4, osmolarity 300 ± 5 mOsM/l. After 30 min of incubation in the
enzyme solution, the tissue was rinsed three times with the low-Ca2+
HEPES-buffered saline solution and triturated using three fire-polished Pas-
teur pipettes having tips of decreasing diameter. Before whole-cell recording,
the cell suspension was placed into a 50 mm transparent plastic Petri dish that
was mounted onto the stage of an inverted microscope. CA2 and CA3 pyrami-
dal neurons were selected on the basis of their characteristic morphology.
For whole-cell recording experiments, glutamate (1 mM) and/or drug perfu-
sion was carried out with a 16-barrel pipette array made from small-diameter
(600 mm2 i.d.) glass capillary tubing. The pipette array was positioned 100–
200 mm from the cell and was moved using a DC actuator. Electronic valves
controlled the gravity-induced flow of each solution from a 10 ml syringe to
an individual barrel. The solutions from the drug array were changed
(100ms) by altering the array position with a DC actuator (Newport, Irvine, CA).
For experiments using the outside-out patch recording configuration, glass
recording electrodes were prepared as described above, and the internal
electrode solution contained 115 mMCsMeSO3, 20 mMCsCl, 10 mMHEPES,
2.5 mM MgCl2, 4 mM Na2-ATP, 0.4 mM Na-GTP, 10 mM phosphocreatine,
0.6 mM EGTA, 0.1 mM spermine, 1 mM QX314 (pH 7.2 ± 0.03), 300 ±
2 mOsm. Cells initially were placed into a Petri dish containing the follow-
ing solution: 119 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1.3 mM MgSO4,
2.7 mM MgCl2, 1 mM NaH2PO4, 26 mM NaHCO3, 11 mM glucose (pH 7.3,
300 ± 2 mOsm). In order to accurately measure deactivation and desensitiza-
tion kinetics, ultrafast ligand perfusion was carried out using a theta tube con-
structed from double-barrel borosilicate glass tubing (catalog #TGC200-4;
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diameter of each barrel was 125 mm, and the septum between barrels was
80 mm. The theta tube position was shifted using a piezoelectric actuator
(Burleigh Instruments, Fishers, NY) having a charging time of 0.3 ms. Onset-
to-offset time of junction potential measurements (0.1 and 1.0 M NaCl) was
700 ms. Solutions were delivered to the theta tubing using the gravity-induced
flow method described above. A high concentration of glutamate (100 mM)
was applied to outside-out patches in order to evoke AMPA receptor-medi-
ated currents. The osmolarity of the extracellular solution was adjusted ac-
cordingly by reducing NaCl. For recordings from primary culture neurons
and acutely isolated hippocampal CA2 and CA3 neurons, the extracellular so-
lution also contained picrotoxin (100 mM) and/or bicuculline (20 mM) to block g-
aminobutyric acidA receptors and 3-(2-carboxypiperazin-4-yl)-propyl-1-phos-
phonic acid (CPP; 10 mM) or 2-amino-5-phosphonovaleric acid (APV; 50 mM) to
block N-methyl-D-aspartate receptors, LY382884 (10 mM) to block kainate re-
ceptors, and tetrodotoxin (500 nM) to block synaptic transmission.
Trafficking Assay
HA-tagged GluR1iQ (Chen et al., 2000; Vandenberghe et al., 2005a) and non-
tagged GluR2iR cDNAs driven by a CMV promoter were used to analyze sur-
face expression of GluRs. CHO cells on poly-D-lysine-coated coverslips in 35
mm dishes were transfected with cDNAs encoding GluR (160 ng), g-subunits
(40 ng), and mock vector pcDNA3 (750 ng) using Fugene 6 (Roche). Cells
were incubated for 36–48 hr after transfection in 20mMNBQX. Anti-N-terminal
GluR2 (Millipore, MAB397, 1:60) or anti-HA (Covance, 16B12, 1:1000) were di-
luted inDMEM+5%FBSwereadded to the transfectedcells at 37C for 30min.
Cells were briefly washed with HBSS and then fixed with 4% PFA in PBS for
30minat 4C, followedbywashing inPBS for 15min twice. Surface-labeled pri-
mary antibodies were visualized by anti-mouse IgG conjugated with Alexa 488
(Invitrogen). Thecellswere thenpermeabilizedwithPBScontaining0.1%Triton
X-100and5%normal goat serum for 30minat 22C followedby incubationwith
anti-C-terminal GluR1 (Millipore, AB1504, 1:200) or anti-C-terminal GluR2/3
(Millipore, AB1506, 1:200). The GluR antibodies labeling internal GluRs were
visualizedbyanti-rabbit IgGconjugatedwithAlexa 568 (Invitrogen). The stained
cells were mounted with Fluoromount-G on slide glasses.
Fromeachcoverslip,12 imageswereacquiredwithaDM6000B (Leica)micro-
scope equipped with a320 objective and chilled CCD, Spot RTKE (Diagnostic
Instruments) at fixed camera gain and exposure time. Optical fields were deter-
mined to includeGluR-positive cells by observing total GluR labeling (red chan-
nel). To eliminate bias, fields were selected by an investigator blinded with re-
spect to surface GluRs labeling. The images were thresholded at a fixed level
using Image J 1.37v software (NIH), and cells above threshold were counted.
BS3 surface crosslinking was performed as described (Hall and Soderling,
1997). Briefly, the transfectants (CHO cells) were grown in 35 mm dishes. The
cells were washed with PBS, including Ca2+ and Mg2+ twice, and then
incubatedwith 1ml of 1mg/ml of BS3 (Pierce) in PBS at 22C for 20m. The cells
werewashedbyPBScontaining100mMethanolamine (pH7.5) twice toquench
the excessBS3, followedby harvestingwith 100 ml of Laemmli buffer containing
500 mM ethanolamine (pH 7.5). Twenty microliters of the samples was
separated by SDS-PAGE and then blotted with anti-GluR1 or anti-GluR2
antibodies.
SUPPLEMENTAL DATA
The Supplemental Data include six figures and can be found with this article
online at http://www.neuron.org/cgi/content/full/59/6/986/DC1/.
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